HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thamer H Albekairi Selected Research

biphalin

11/2021Glutamate Buffering Capacity and Blood-Brain Barrier Protection of Opioid Receptor Agonists Biphalin and Nociceptin.
9/2019Brain Delivery of a Potent Opioid Receptor Agonist, Biphalin during Ischemic Stroke: Role of Organic Anion Transporting Polypeptide (OATP).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thamer H Albekairi Research Topics

Disease

4Autistic Disorder (Autism)
01/2022 - 02/2021
4Ischemic Stroke
11/2021 - 11/2018
3Stroke (Strokes)
11/2021 - 11/2018
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2022 - 01/2022
1Whipple Disease (Whipple's Disease)
04/2022
1Infections
04/2022
1Parkinson Disease (Parkinson's Disease)
04/2022
1Demyelinating Diseases (Demyelinating Disease)
01/2022
1Memory Disorders (Memory Loss)
01/2022
1Pain (Aches)
11/2021
1Reperfusion Injury
11/2021
1Wounds and Injuries (Trauma)
08/2020
1Inflammation (Inflammations)
08/2020
1Kidney Neoplasms (Kidney Cancer)
08/2020
1Brain Edema (Cerebral Edema)
01/2019
1Drug-Related Side Effects and Adverse Reactions
01/2019
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2018
1Edema (Dropsy)
11/2018
1Infarction (Infarctions)
11/2018
1Ischemia
11/2018

Drug/Important Bio-Agent (IBA)

2Peptides (Polypeptides)IBA
04/2022 - 09/2019
2Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2022
2Pharmaceutical PreparationsIBA
01/2022 - 08/2020
2biphalinIBA
11/2021 - 09/2019
2Opioid Receptors (Opioid Receptor)IBA
11/2021 - 09/2019
2Glutamic Acid (Glutamate)FDA Link
11/2021 - 01/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 11/2018
1VaccinesIBA
04/2022
1beta-LactamsIBA
04/2022
1Anti-Bacterial Agents (Antibiotics)IBA
04/2022
1Tetracycline (Achromycin)FDA LinkGeneric
04/2022
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2022
1tofacitinibIBA
04/2022
1Janus Kinase InhibitorsIBA
04/2022
1Cathepsin BIBA
01/2022
1SB-332235IBA
01/2022
1methylmercuric chlorideIBA
01/2022
1Chemokine ReceptorsIBA
01/2022
1UCB 35625IBA
01/2022
1N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA
01/2022
1Neuroprotective AgentsIBA
11/2021
1NociceptinIBA
11/2021
1Excitatory Amino AcidsIBA
11/2021
1Opioid Analgesics (Opioids)IBA
11/2021
1Therapeutic UsesIBA
02/2021
1Interleukin-9 (Interleukin 9)IBA
02/2021
15-aminoisoquinolinoneIBA
02/2021
1Interleukin-10 (Interleukin 10)IBA
02/2021
1Interleukin-17 (Interleukin 17)IBA
02/2021
1Lipid PeroxidesIBA
02/2021
1NADPH Oxidases (NAD(P)H oxidase)IBA
02/2021
1phthalic acid (phthalate)IBA
02/2021
1EnzymesIBA
02/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
02/2021
1Diethylhexyl Phthalate (DEHP)IBA
02/2021
1AntioxidantsIBA
02/2021
13-nitrotyrosineIBA
02/2021
1Oxidants (Oxidizing Agents)IBA
02/2021
1RivaroxabanIBA
08/2020
1Sunitinib (Sutent)FDA Link
08/2020
1AnionsIBA
09/2019
1Oxygen (Dioxygen)IBA
11/2018
1Inositol (Myoinositol)IBA
11/2018

Therapy/Procedure

1Therapeutics
01/2022